Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Celiac Disease Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Celiac Disease Drugmarket, defines the market attractiveness level of Celiac Disease Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Celiac Disease Drug industry, describes the types of Celiac Disease Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Celiac Disease Drug market and the development prospects and opportunities of Celiac Disease Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Celiac Disease Drug market in Chapter 13.
By Player:
Bristol-Myers Squibb
Merck
Biotest
BioLineRx
Takeda Pharmaceutical
Anthera Pharmaceuticals
Kedrion Biopharma
F Hoffmann-La Roche
Johnson & Johnson
Amgen
Bayer
LFB Group
Pfizer
ADMA Biologics
Celgene
Novartis
Biogen
By Type:
Distension
Diarrhea
Anorexia
Others
By End-User:
First line of treatment
Second line of treatment
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Celiac Disease Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Celiac Disease Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Celiac Disease Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Celiac Disease Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Celiac Disease Drug Market Analysis and Outlook to 2022
-
7.1 Global Celiac Disease Drug Consumption (2017-2022)
-
7.2 United States Celiac Disease Drug Consumption (2017-2022)
-
7.3 Europe Celiac Disease Drug Consumption (2017-2022)
-
7.4 China Celiac Disease Drug Consumption (2017-2022)
-
7.5 Japan Celiac Disease Drug Consumption (2017-2022)
-
7.6 India Celiac Disease Drug Consumption (2017-2022)
-
7.7 South Korea Celiac Disease Drug Consumption (2017-2022)
8 Region and Country-wise Celiac Disease Drug Market Analysis and Outlook to 2028
-
8.1 Global Celiac Disease Drug Consumption Forecast (2022-2028)
-
8.2 United States Celiac Disease Drug Consumption Forecast (2022-2028)
-
8.3 Europe Celiac Disease Drug Consumption Forecast (2022-2028)
-
8.4 China Celiac Disease Drug Consumption Forecast (2022-2028)
-
8.5 Japan Celiac Disease Drug Consumption Forecast (2022-2028)
-
8.6 India Celiac Disease Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Celiac Disease Drug Consumption Forecast (2022-2028)
9 Global Celiac Disease Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Celiac Disease Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Distension Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Diarrhea Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Anorexia Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Celiac Disease Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global First line of treatment Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Second line of treatment Consumption and Growth Rate (2017-2022)
10 Global Celiac Disease Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Celiac Disease Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Distension Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Diarrhea Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Anorexia Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Celiac Disease Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global First line of treatment Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Second line of treatment Consumption Forecast and Growth Rate (2022-2028)
11 Global Celiac Disease Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Celiac Disease Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Celiac Disease Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Celiac Disease Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Celiac Disease Drug Market Competitive Analysis
-
14.1 Bristol-Myers Squibb
-
14.1.1 Bristol-Myers Squibb Company Details
-
14.1.2 Bristol-Myers Squibb Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bristol-Myers Squibb Celiac Disease Drug Product and Service
-
14.2 Merck
-
14.2.1 Merck Company Details
-
14.2.2 Merck Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck Celiac Disease Drug Product and Service
-
14.3 Biotest
-
14.3.1 Biotest Company Details
-
14.3.2 Biotest Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Biotest Celiac Disease Drug Product and Service
-
14.4 BioLineRx
-
14.4.1 BioLineRx Company Details
-
14.4.2 BioLineRx Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 BioLineRx Celiac Disease Drug Product and Service
-
14.5 Takeda Pharmaceutical
-
14.5.1 Takeda Pharmaceutical Company Details
-
14.5.2 Takeda Pharmaceutical Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Takeda Pharmaceutical Celiac Disease Drug Product and Service
-
14.6 Anthera Pharmaceuticals
-
14.6.1 Anthera Pharmaceuticals Company Details
-
14.6.2 Anthera Pharmaceuticals Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Anthera Pharmaceuticals Celiac Disease Drug Product and Service
-
14.7 Kedrion Biopharma
-
14.7.1 Kedrion Biopharma Company Details
-
14.7.2 Kedrion Biopharma Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Kedrion Biopharma Celiac Disease Drug Product and Service
-
14.8 F Hoffmann-La Roche
-
14.8.1 F Hoffmann-La Roche Company Details
-
14.8.2 F Hoffmann-La Roche Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 F Hoffmann-La Roche Celiac Disease Drug Product and Service
-
14.9 Johnson & Johnson
-
14.9.1 Johnson & Johnson Company Details
-
14.9.2 Johnson & Johnson Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Johnson & Johnson Celiac Disease Drug Product and Service
-
14.10 Amgen
-
14.10.1 Amgen Company Details
-
14.10.2 Amgen Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Amgen Celiac Disease Drug Product and Service
-
14.11 Bayer
-
14.11.1 Bayer Company Details
-
14.11.2 Bayer Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Bayer Celiac Disease Drug Product and Service
-
14.12 LFB Group
-
14.12.1 LFB Group Company Details
-
14.12.2 LFB Group Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 LFB Group Celiac Disease Drug Product and Service
-
14.13 Pfizer
-
14.13.1 Pfizer Company Details
-
14.13.2 Pfizer Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Pfizer Celiac Disease Drug Product and Service
-
14.14 ADMA Biologics
-
14.14.1 ADMA Biologics Company Details
-
14.14.2 ADMA Biologics Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 ADMA Biologics Celiac Disease Drug Product and Service
-
14.15 Celgene
-
14.15.1 Celgene Company Details
-
14.15.2 Celgene Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Celgene Celiac Disease Drug Product and Service
-
14.16 Novartis
-
14.16.1 Novartis Company Details
-
14.16.2 Novartis Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Novartis Celiac Disease Drug Product and Service
-
14.17 Biogen
-
14.17.1 Biogen Company Details
-
14.17.2 Biogen Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 Biogen Celiac Disease Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Celiac Disease Drug
-
Figure Celiac Disease Drug Picture
-
Table Global Celiac Disease Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Celiac Disease Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Celiac Disease Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Celiac Disease Drug Consumption by Country (2017-2022)
-
Figure United States Celiac Disease Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Celiac Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure China Celiac Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Celiac Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure India Celiac Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Celiac Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Celiac Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Celiac Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Celiac Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Celiac Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Celiac Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Celiac Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Celiac Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Distension Consumption and Growth Rate (2017-2022)
-
Figure Global Diarrhea Consumption and Growth Rate (2017-2022)
-
Figure Global Anorexia Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global First line of treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Second line of treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Distension Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diarrhea Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anorexia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global First line of treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Second line of treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Celiac Disease Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Celiac Disease Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Celiac Disease Drug Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Celiac Disease Drug Product and Service
-
Table Biotest (Foundation Year, Company Profile and etc.)
-
Table Biotest Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biotest Celiac Disease Drug Product and Service
-
Table BioLineRx (Foundation Year, Company Profile and etc.)
-
Table BioLineRx Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioLineRx Celiac Disease Drug Product and Service
-
Table Takeda Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Celiac Disease Drug Product and Service
-
Table Anthera Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Anthera Pharmaceuticals Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Anthera Pharmaceuticals Celiac Disease Drug Product and Service
-
Table Kedrion Biopharma (Foundation Year, Company Profile and etc.)
-
Table Kedrion Biopharma Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kedrion Biopharma Celiac Disease Drug Product and Service
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Celiac Disease Drug Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Celiac Disease Drug Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Celiac Disease Drug Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Celiac Disease Drug Product and Service
-
Table LFB Group (Foundation Year, Company Profile and etc.)
-
Table LFB Group Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table LFB Group Celiac Disease Drug Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Celiac Disease Drug Product and Service
-
Table ADMA Biologics (Foundation Year, Company Profile and etc.)
-
Table ADMA Biologics Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table ADMA Biologics Celiac Disease Drug Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Celiac Disease Drug Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Celiac Disease Drug Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Celiac Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Celiac Disease Drug Product and Service
-
